Uncategorized


You Recently Saw A Friend Who Has Since Been Diagnosed With COVID-19. Should You Get Tested? The CDC Says No.

Public health officials across the country, however, reaffirm that yes, you should. The new guidelines for the novel coronavirus were issued by the Center for Disease Control and Prevention (CDC) this week. The circumstances surrounding the announcement are murky. Reports say the guidance was put together by the White House coronavirus task force, and that Dr. Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases (NIAID), was not aware.


Three Cs Aided In Halting Japan’s COVID-19 State Of Emergency in May. Why Are Cases Spiking Now?

The country is now coming under criticism for opening too soon, as numbers have spiked over the summer. Johns Hopkins data shows there have been 28,000 new cases in August alone, taking the nation’s case total to more than 64,000. “This is the result of the government prioritizing economic activity — by getting people to move around again — over infection control,” Yoshihito Niki, a professor of infectious diseases at Showa University’s School of Medicine told Bloomberg this week.


Is Anxiety The Next Epidemic To Hit America? Multiple Studies Show Concerning, Elevated Levels in 2020.

Internet searches for acute anxiety were at an all-time high in the U.S. between March 13 and May 9 2020, according to a new study by the University of California, San Diego. The research published in JAMA this week utilized Google Trends data going back to 2004, and found that acute anxiety queries were cumulatively 11% higher than expected during the first two months of the novel coronavirus outbreak.


Advances in CRISPR: Diagnosing And Inhibiting COVID-19

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats. Charles Chiu, a UCSF professor of laboratory medicine as well as an MD, published a paper in the journal Nature in April 2020 that is expanding the way CRISPR can be used. The paper details a new test that he developed called DETECTR that uses CRISPR to diagnose COVID-19. The advantage of this assay over other diagnostic tools is that it provides expedited results, and does not require hospitals to invest in special equipment.